New heart monitor aims to keep patients out of hospital
NCT ID NCT06641921
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a remote monitoring system called Seerlinq HeartCore in 330 heart failure patients. Participants used a device at home to measure heart function and report symptoms. The goal was to see if this approach could reduce hospitalizations and deaths over 6 months. The results could improve how doctors manage heart failure remotely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Seerlinq HeartCore telemedical monitoring system (device)
- What this could lead to
- If successful, this could show that remote monitoring helps heart failure patients avoid hospital stays and live longer at home.
- What could go wrong
- This is a single-arm trial without a comparison group, so benefits may be due to other factors. The device is not a cure and requires ongoing medication adjustments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Premedix Clinic
Bratislava, Nové Mesto, 831 01, Slovakia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can shedding pounds reboot the Heart's exercise engine?